According to Novo Integrated Sciences's latest financial reports the company has $0.65 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-08-31 | $0.41 M | -80.89% |
2022-08-31 | $2.17 M | -73.73% |
2021-08-31 | $8.29 M | 301.08% |
2020-08-31 | $2.06 M | -0.77% |
2019-08-31 | $2.08 M | 208.37% |
2018-08-31 | $0.67 M | -64.37% |
2017-08-31 | $1.89 M | 1619.23% |
2016-12-31 | $0.05 M | 284.83% |
2016-08-31 | $0.11 M | |
2015-12-31 | $0.01 M | 671.33% |
2014-12-31 | $0 M | -46.51% |
2013-12-31 | $0 M | -45.61% |
2012-12-31 | $0 M | -45.93% |
2011-12-31 | $0.01 M | -90.93% |
2010-12-31 | $0.12 M | -78.75% |
2009-12-31 | $0.6 M | 21027.09% |
2008-12-31 | $0 M | 1.24% |
2007-12-31 | $0 M | 160.81% |
2006-12-31 | $0 M | -91.98% |
2005-12-31 | $0.01 M | 49851.85% |
2004-12-31 | $0 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Select Medical Holdings SEM | $0.14 B | 21,836.12% | ๐บ๐ธ USA |
HealthSouth
EHC | $69.1 M | 10,502.27% | ๐บ๐ธ USA |
Novo Integrated Sciences NVOS | $0.65 M | 0.00% | ๐บ๐ธ USA |